Literature DB >> 3311151

Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the gamma-chain. Sequence of carboxy-terminal cyanogen bromide gamma-chain fragments.

L Purves1, M Purves, W Brandt.   

Abstract

Puff adder venom contains a protease capable of cleaving the gamma-chain of cross-linked D-dimer, derived from the plasmin digestion of fibrin, into apparently symmetrical monomers. The cross-linked gamma-chains are separated in the process without apparent loss of mass and without loss of the substituent at the glutamine cross-link site, if fluorescent D-dimer (the lysine analogue dansylcadaverine used as substituent) is used as substrate [Purves, L. R., Purves, M., Lindsey, G. G., & Linton, N. J. (1986) S. Afr. J. Sci. 82, 30]. The gamma-chain from puff adder venom digested D-monomer was isolated and cleaved by cyanogen bromide, and the carboxy-terminal peptide was isolated and sequenced. The carboxy-terminal peptide composition indicated a lower content of histidine, leucine, and glycine than expected. Manual microsequencing by gas-phase Edman degradation demonstrated that two amino-terminal ends were present. By use of the known sequence of the human fibrinogen gamma-chain, the sequencing data could be resolved into a dipeptide cross-linked between lysine-406 and either glutamine-398 or -399 (residues 6 and 13 or 14 from the carboxy-terminal end of the gamma-chain) with the loss of residues 401-404 that occur between the cross-link sites of both antiparallel cross-linked gamma-chains. D-dimer is therefore separated into monomers by cleavage of the gamma-chain between the cross-link sites. Two symmetrical fragments are produced consisting of a cross-linked dipeptide with the loss of four amino acids.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311151     DOI: 10.1021/bi00389a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Transglutaminase-catalyzed crosslinking of the Aalpha and gamma constituent chains in fibrinogen.

Authors:  S N Murthy; J H Wilson; T J Lukas; Y Veklich; J W Weisel; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin.

Authors:  M W Mosesson; K R Siebenlist; D L Amrani; J P DiOrio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Structure of the fibrinogen gamma-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization.

Authors:  S Ware; J P Donahue; J Hawiger; W F Anderson
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

4.  The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains.

Authors:  M W Mosesson; K R Siebenlist; D A Meh; J S Wall; J F Hainfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

5.  Localization of transglutaminase-reactive glutamine residues in bovine osteopontin.

Authors:  E S Sørensen; L K Rasmussen; L Møller; P H Jensen; P Højrup; T E Petersen
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

Review 6.  Biophysical Mechanisms Mediating Fibrin Fiber Lysis.

Authors:  Nathan E Hudson
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

7.  Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.

Authors:  Cédric Duval; Adomas Baranauskas; Tímea Feller; Majid Ali; Lih T Cheah; Nadira Y Yuldasheva; Stephen R Baker; Helen R McPherson; Zaher Raslan; Marc A Bailey; Richard M Cubbon; Simon D Connell; Ramzi A Ajjan; Helen Philippou; Khalid M Naseem; Victoria C Ridger; Robert A S Ariëns
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.